ALTEA THERAPEUTICS
Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The company also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention prod... ucts; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. Altea Therapeutics Corporation was formerly known as Altea Development Corporation. The company was founded in 1998 and is based in Atlanta, Georgia. As of May 9, 2012, Altea Therapeutics Corporation operates as a subsidiary of Nitto Denko Corp.
ALTEA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.alteatherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(404)835-6310
Total Funding:
83.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager Content Delivery Network Organization Schema Google Maps ReCAPTCHA Cloudflare JS CDN JS
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Current Employees Featured
Founder
Investors List
Aperture Venture Partners
Aperture Venture Partners investment in Series C - Altea Therapeutics
Aperture Venture Partners
Aperture Venture Partners investment in Series C - Altea Therapeutics
Domain Associates
Domain Associates investment in Series B - Altea Therapeutics
Official Site Inspections
http://www.alteatherapeutics.com
- Host name: 172.67.208.18
- IP address: 172.67.208.18
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Altea Therapeutics"
Altea Therapeutics - Crunchbase Company Profile
Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts …See details»
Altea Therapeutics Company Profile | Management and ... - Datanyze
Www.alteatherapeutics.com Altea Therapeutics Profile and History Altea Therapeutics is a privately held clinical-stage pharmaceutical company with a proprietary platform technology …See details»
Altea Therapeutics Corp. - Drug pipelines, Patents, Clinical trials ...
Explore Altea Therapeutics Corp. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 4 literature.See details»
Altea Therapeutics Corp - Company Profile and News
Company profile page for Altea Therapeutics Corp including stock price, company news, executives, board members, and contact informationSee details»
Altea Therapeutics Management Team | Org Chart - RocketReach
Altea Therapeutics has made a key scientific and commercial breakthrough in the delivery of drugs and vaccines via the skin. The PassPort® patch, a cost-effective and easy to use skin …See details»
Altea Therapeutics - Overview, News & Similar companies
Apr 10, 2018 Who is Altea Therapeutics. Altea Therapeutics is a privately held clinical-stage pharmaceutical company with a proprietary platform technology broadly applicable to the bolus …See details»
Altea Therapeutics - Products, Competitors, Financials, Employees ...
Altea Therapeutics. Frequently Asked Questions (FAQ). When was Altea Therapeutics founded? Altea Therapeutics was founded in 1998. Where is Altea Therapeutics's headquarters? Altea …See details»
Altea Therapeutics Announces Development and …
Mar 31, 2009 Altea Therapeutics is privately held clinical-stage pharmaceutical company with a proprietary platform technology broadly applicable to the transdermal delivery of biological …See details»
Altea Therapeutics - VentureRadar
"Conventional transdermal system are typically limited to lipid-soluble drugs with a molecular weight of less than 500 daltons. The PassPort® System enables continuous delivery of …See details»
Altea Therapeutics - VentureRadar
Website: http://www.alteatherapeutics.com/ Conventional transdermal system are typically limited to lipid-soluble drugs with a molecular weight of less than 500 daltons.See details»
Nitto Denko acquires all assets of Altea Therapeutics
May 14, 2012 Japan's leading diversified materials manufacturer, Nitto Denko Corporation, today announced that it has acquired all the assets including patents, trademarks and laboratory …See details»
Altea Therapeutics | Insights
Oct 25, 2022 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Altea Therapeutics and Hospira enter into Development and ...
Jul 2, 2008 About Altea Therapeutics. Altea Therapeutics is an emerging specialty pharmaceutical company developing and commercializing products based on a new …See details»
Home | Altay Tx
Developing life-saving therapies by targeting disease-causing transcription factors. Our Pipeline. Our TechnologySee details»
Rick Bright - Immunologist at Altea Therapeutics - ZoomInfo
Rick Bright is a Director, Immunologist, Virologist & of The Biomedical Advanced Research & Development Authority Deputy Assistant Secretary at Preparedness & Response based in …See details»
Working at Altea Therapeutics - Glassdoor
See what employees say it's like to work at Altea Therapeutics. Salaries, reviews, and more - all posted by employees working at Altea Therapeutics.See details»
Altea and KAI Enter into a Preclinical and Clinical Development ...
Jan 14, 2010 Agreement aims at the delivery of certain KAI compounds using Altea’s transdermal delivery technology.See details»
Altea Therapeutics Announces Development and ... - BioSpace
Apr 1, 2009 Altea Therapeutics to Receive Upfront License Payment, R&D Funding, and Equity Investment, Eligible for Future Milestones and for Royalties ATLANTA--(BUSINESS WIRE)- …See details»
Halia - Revolutionizing Chronic Inflammation Therapy
Inflammation is an essential biological response of the human immune system that protects against disease. However, when dysregulated, inflammation can become a driver of disease …See details»